# A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

> **NCT07746765** · — · NOT_YET_RECRUITING · sponsor: **Janssen Sciences Ireland UC** · enrollment: 35 (estimated)

## Conditions studied

- Crohn Disease
- Colitis, Ulcerative

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07746765
- **Lead sponsor:** Janssen Sciences Ireland UC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2029-08-03
- **Final completion:** 2029-10-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746765, "A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*